Page last updated: 2024-09-04

febuxostat and Parkinsonian Disorders

febuxostat has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hu, L; Li, Q; Yan, W; Zhang, Y; Zhou, H	1

Other Studies

1 other study(ies) available for febuxostat and Parkinsonian Disorders

Article	Year
Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes. Neurotoxicity research, 2021, Volume: 39, Issue:3 Topics: 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Cells, Cultured; Dose-Response Relationship, Drug; Febuxostat; Gout Suppressants; Inflammation Mediators; MAP Kinase Signaling System; NF-kappa B; Parkinsonian Disorders; Rats; Rats, Wistar	2021

Article

Year

Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes.

Neurotoxicity research, 2021, Volume: 39, Issue:3

Topics: 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Cells, Cultured; Dose-Response Relationship, Drug; Febuxostat; Gout Suppressants; Inflammation Mediators; MAP Kinase Signaling System; NF-kappa B; Parkinsonian Disorders; Rats; Rats, Wistar

2021